PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 46 filers reported holding PROFOUND MED CORP in Q3 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $890,195 | -45.1% | 87,274 | -29.9% | 0.10% | -48.3% |
| Q2 2023 | $1,620,773 | -17.2% | 124,579 | -40.9% | 0.20% | -23.4% |
| Q1 2023 | $1,958,100 | -39.4% | 210,775 | -29.0% | 0.26% | -43.7% |
| Q4 2022 | $3,230,704 | +201.1% | 296,667 | +11.7% | 0.47% | +101.3% |
| Q3 2022 | $1,073,000 | -42.5% | 265,667 | +3.7% | 0.23% | -34.1% |
| Q2 2022 | $1,867,000 | -14.2% | 256,167 | +6.0% | 0.36% | +22.4% |
| Q1 2022 | $2,175,000 | -17.3% | 241,667 | +3.2% | 0.29% | +36.8% |
| Q4 2021 | $2,630,000 | -19.0% | 234,167 | +5.6% | 0.21% | -5.8% |
| Q3 2021 | $3,245,000 | -10.5% | 221,667 | 0.0% | 0.22% | +3.2% |
| Q2 2021 | $3,626,000 | -0.8% | 221,667 | +22.1% | 0.22% | -14.2% |
| Q1 2021 | $3,657,000 | -2.6% | 181,589 | -0.5% | 0.25% | +6.7% |
| Q4 2020 | $3,754,000 | +80.2% | 182,589 | +54.6% | 0.24% | +68.8% |
| Q3 2020 | $2,083,000 | -34.3% | 118,089 | -36.9% | 0.14% | -57.8% |
| Q2 2020 | $3,169,000 | – | 187,089 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 196,924 | $3,474,000 | 8.11% |
| Gagnon Advisors, LLC | 277,252 | $4,891,000 | 3.00% |
| GAGNON SECURITIES LLC | 779,533 | $13,751,000 | 2.93% |
| Taylor Wealth Management Partners | 166,364 | $2,935,000 | 1.34% |
| AWM Investment Company, Inc. | 348,939 | $6,155,000 | 1.01% |
| PCJ Investment Counsel Ltd. | 121,560 | $2,137,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 780,567 | $13,769,000 | 0.71% |
| Parkman Healthcare Partners LLC | 70,000 | $1,235,000 | 0.33% |
| Park West Asset Management LLC | 450,000 | $7,938,000 | 0.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 695,000 | $12,260,000 | 0.30% |